Chymase as an Important Target for Preventing Complications of Metabolic Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|28|3223-3229

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.28, 2010-09, pp. : 3223-3229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NAD(P)H Oxidase Activation: A Potential Target Mechanism for Diabetic Vascular Complications, Progressive &bgr;-Cell Dysfunction and Metabolic Syndrome

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 495-501

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Statins in Preventing the Progression of Congestive Heart Failure in Patients with Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2605-2612

Bentham Science Publishers

Access to resources Recommend Favorite

Sufficient Weight Reduction Decreases Cardiovascular Complications in Diabetic Patients with the Metabolic Syndrome

By  

Heart Drug, Vol. 5, Iss. 2, 2005-03 ,pp. : 68-74

Karger

Access to resources Recommend Favorite

Moderate Wine Consumption in the Prevention of Metabolic Syndrome and its Related Medical Complications

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 2, 2008-06 ,pp. : 89-98

Bentham Science Publishers

Access to resources Recommend Favorite

The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome

By Simão Andréa Name Colado   Lozovoy Marcell Alysson Batisti   Dichi Isaias  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1175-1187

Informa Healthcare

Access to resources Recommend Favorite